Search hospitals > Washington > Spokane
Cancer Care Northwest - Spokane South
Claim this profileSpokane, Washington 99202
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
262 reported clinical trials
5 medical researchers
Summary
Cancer Care Northwest - Spokane South is a medical facility located in Spokane, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Cancer Care Northwest - Spokane South is involved with conducting 262 clinical trials across 264 conditions. There are 5 research doctors associated with this hospital, such as Chanh T. Huynh, Rafael Santana-Davila, MD, Kristine Rinn, MD, and Janice N. Kim.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 positive
HER2 negative
ER positive
Top PIs
Chanh T. HuynhAdams Cancer Center1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
37 drugs studied
Rafael Santana-Davila, MDSeattle Cancer Care Alliance5 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Kristine Rinn, MDCancer Care Northwest1 year of reported clinical research
Studies Breast Cancer
Studies Brain Tumor
6 reported clinical trials
13 drugs studied
Janice N. KimSeattle Cancer Care Alliance5 years of reported clinical research
Studies Breast Cancer
4 reported clinical trials
8 drugs studied
Clinical Trials running at Cancer Care Northwest - Spokane South
Non-Small Cell Lung Cancer
Lung Cancer
ALK Gene Rearrangement
Solid Tumors
Non-Hodgkin's Lymphoma
Head and Neck Squamous Cell Carcinoma
Colorectal Cancer
Cancer
Gene Mutation
APC Gene Mutation
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Tiragolumab + Atezolizumab
for Lung Cancer
This trial is testing whether adding tiragolumab to atezolizumab is more effective than using atezolizumab alone in patients with non-small cell lung cancer who have had surgery and chemotherapy. The goal is to see if this combination can better help the immune system fight cancer. The study compares the new combination to atezolizumab alone to measure its effectiveness and safety.
Recruiting1 award Phase 3
MCLA-158
for Solid Cancers
This trial is testing a new drug called MCLA-158 to see if it can help treat certain cancers by blocking a protein that helps cancer cells grow. It focuses on patients with cancers that rely on this protein, like colorectal and head and neck cancers.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cancer Care Northwest - Spokane South?
Cancer Care Northwest - Spokane South is a medical facility located in Spokane, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Cancer Care Northwest - Spokane South is involved with conducting 262 clinical trials across 264 conditions. There are 5 research doctors associated with this hospital, such as Chanh T. Huynh, Rafael Santana-Davila, MD, Kristine Rinn, MD, and Janice N. Kim.